β¨ Medicines and Justice Notices
1146 NEW ZEALAND GAZETTE No. 52
Product:
Zyban
Active Ingredient(s):
Bupropion hydrochloride 150mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Glaxo Wellcome New Zealand Limited
Manufacturer(s):
Glaxo Wellcome Inc, Zebulon, North Carolina, United States of America
Dated this 11th day of May 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go3517
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the act and are set out in the schedule hereto:
Schedule
Product:
NovoNorm
Active Ingredient(s):
Repaglinide 0.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturer(s):
Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany
Product:
NovoNorm
Active Ingredient(s):
Repaglinide 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturer(s):
Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany
Product:
NovoNorm
Active Ingredient(s):
Repaglinide 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturer(s):
Boehringer Ingelheim Pharma KG, Ingelheim am Rhein, Germany
Product:
Xeloda
Active Ingredient(s):
Capecitabine 150mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer(s):
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom
Note: This product has provisional consent.
Product:
Xeloda
Active Ingredient(s):
Capecitabine 500mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer(s):
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom
Note: This product has provisional consent.
Dated this 11th day of May 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go3516
Justice
District Courts Act 1947
Acting District Court Judge Appointed
Pursuant to section 10A of the District Courts Act 1947, His Excellency the Governor-General has been pleased to appoint
Eric Bernard Anderson, retired District Court Judge
to be an Acting District Court Judge, to exercise civil and criminal jurisdiction in New Zealand, and to exercise the criminal jurisdiction of the District Courts under Part IIA of the District Courts Act 1947, at such place or places and for such period or periods only as the Chief District Court Judge may fix, pursuant to the said section 10A of the District Courts Act 1947, for a term of two years on and from the 2nd day of June 2000.
Dated at Wellington this 10th day of May 2000.
MARGARET WILSON, Attorney-General.
go3559
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 52
Gazette.govt.nz —
NZ Gazette 2000, No 52
β¨ LLM interpretation of page content
π₯ Approval of Zyban (Bupropion hydrochloride) Tablets
π₯ Health & Social Welfare11 May 2000
Medicine, Tablet, Bupropion hydrochloride, Zyban
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social Welfare11 May 2000
Medicines, Distribution, NovoNorm, Xeloda
- G. R. Boyd, Chief Advisor, Safety and Regulation
βοΈ Appointment of Acting District Court Judge
βοΈ Justice & Law Enforcement10 May 2000
Justice, District Court Judge, Appointment
- Eric Bernard Anderson (retired District Court Judge), Appointed Acting District Court Judge
- Margaret Wilson, Attorney-General